Drug name - Xofluza

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8987441 GENENTECH INC Substituted polycyclic carbamoyl pyridone derivative prodrug
Sep, 2031

(8 years from now)

US10392406 GENENTECH INC Substituted polycyclic pyridone derivatives and prodrugs thereof
Apr, 2036

(13 years from now)

US10759814 GENENTECH INC Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
Aug, 2037

(14 years from now)

CN112876473A GENENTECH INC Substituted Polycyclic Pyridone Derivatives And Prodrugs Thereof
Jun, 2022

(4 months ago)

CN103228653A GENENTECH INC Substituted Polycyclic Carbamoyl Pyridone Derivative Prodrug
Sep, 2031

(8 years from now)

CN103228653B GENENTECH INC Substituted Polycyclic Carbamoyl Pyridone Derivative Prodrug
Sep, 2031

(8 years from now)

CN112940010B GENENTECH INC Substituted Polycyclic Pyridone Derivatives And Prodrugs Thereof
Apr, 2036

(13 years from now)

CN113004304A GENENTECH INC Substituted Polycyclic Pyridone Derivatives And Prodrugs Thereof
Apr, 2036

(13 years from now)

CN112940010A GENENTECH INC Substituted Polycyclic Pyridone Derivatives And Prodrugs Thereof
Apr, 2036

(13 years from now)

CN113004304B GENENTECH INC Substituted Polycyclic Pyridone Derivatives And Prodrugs Thereof
Apr, 2036

(13 years from now)

IN201303057P4 GENENTECH INC Substituted Polycyclic Carbamoyl Pyridone Derivative Prodrug
Sep, 2031

(8 years from now)

IN318238B GENENTECH INC Substituted Polycyclic Carbamoyl Pyridone Derivative Prodrug
Sep, 2031

(8 years from now)

IN346800B GENENTECH INC Substituted Polycyclic Pyridone Derivative And Prodrug Thereof
Apr, 2036

(13 years from now)

IN201747041390A GENENTECH INC Substituted Polycyclic Pyridone Derivative And Prodrug Thereof
Apr, 2036

(13 years from now)

EP2620436A4 GENENTECH INC Substituted Polycyclic Carbamoyl Pyridone Derivative Prodrug
Sep, 2031

(8 years from now)

EP2620436B1 GENENTECH INC Substituted Polycyclic Carbamoyl Pyridone Derivative Prodrug
Sep, 2031

(8 years from now)

EP2620436A1 GENENTECH INC Substituted Polycyclic Carbamoyl Pyridone Derivative Prodrug
Sep, 2031

(8 years from now)

EP3428170A1 GENENTECH INC Anti-Influenza Polycyclic Pyridone Derivative And Prodrug Thereof
Apr, 2036

(13 years from now)

EP3428170B1 GENENTECH INC Anti-Influenza Polycyclic Pyridone Derivative And Prodrug Thereof
Apr, 2036

(13 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9815835 GENENTECH INC Substituted polycyclic carbamolypyridone derivative Jun, 2030

(7 years from now)

US8927710 GENENTECH INC Substituted polycyclic carbamoylpyridone derivative May, 2031

(8 years from now)

US10633397 GENENTECH INC Substituted polycyclic pyridone derivatives and prodrugs thereof Apr, 2036

(13 years from now)

Drugs and Companies using BALOXAVIR MARBOXIL ingredient

Treatment: Method for treating influenza; method for post-exposure prophylaxis of influenza

Dosage: FOR SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
2MG/ML FOR SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.